# Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

> **NCT00005092** · PHASE1 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 7 (actual)

## Conditions studied

- Leukemia
- Lymphoma
- Multiple Myeloma and Plasma Cell Neoplasm
- Myelodysplastic Syndromes

## Interventions

- **DRUG:** Cyclophosphamide
- **DRUG:** Psoralen
- **DRUG:** Thiotepa
- **PROCEDURE:** Allogeneic bone marrow transplantation
- **PROCEDURE:** In vitro-treated peripheral blood stem cell transplantation (PBSCT)
- **RADIATION:** Radiation Therapy (RT)

## Key facts

- **NCT ID:** NCT00005092
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-05-28
- **Primary completion:** 2002-08-28
- **Final completion:** 2002-08-28
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2018-10-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005092

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005092, "Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00005092. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*